Trials / Completed
CompletedNCT02827565
Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer
Prospective Study of Technical Optimization of the Detection of KRAS Mutations, BRAF and NRAS by Next Generation Sequencing on Tumor DNA Circulating in Metastatic Colorectal Cancer.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Institut de Cancérologie de Lorraine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to optimize the search by next-generation sequencing (NGS) mutations in the KRAS, BRAF and NRAS on circulating tumor DNA and compare the genetic profiles obtained with those from tumors embedded in paraffin
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | KRAS, NRAS et BRAF mutation analysis from circulating plasma DNA | 10 ml blood sample |
Timeline
- Start date
- 2016-02-03
- Primary completion
- 2017-01-05
- Completion
- 2017-01-19
- First posted
- 2016-07-11
- Last updated
- 2018-08-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02827565. Inclusion in this directory is not an endorsement.